Advertisement
Australia markets open in 2 hours 33 minutes
  • ALL ORDS

    7,935.70
    -99.20 (-1.23%)
     
  • AUD/USD

    0.6614
    -0.0044 (-0.66%)
     
  • ASX 200

    7,665.60
    -101.10 (-1.30%)
     
  • OIL

    79.28
    -0.55 (-0.69%)
     
  • GOLD

    2,336.90
    -19.60 (-0.83%)
     
  • Bitcoin AUD

    101,998.62
    -1,278.00 (-1.24%)
     
  • CMC Crypto 200

    1,448.88
    -35.81 (-2.41%)
     

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings

Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.